{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:44:56Z","timestamp":1771947896213,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd013743","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000}}],"reference-count":111,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013743.pub2","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T10:08:18Z","timestamp":1652868498000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Antibiotics for the induction and maintenance of remission in ulcerative colitis"],"prefix":"10.1002","volume":"2022","author":[{"given":"Morris","family":"Gordon","sequence":"additional","affiliation":[{"name":"School of Medicine; University of Central Lancashire; Preston UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki","family":"Sinopoulou","sequence":"additional","affiliation":[{"name":"School of Medicine; University of Central Lancashire; Preston UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciaran","family":"Grafton-Clarke","sequence":"additional","affiliation":[{"name":"School of Life Sciences; University of Leicester; Leicester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony K","family":"Akobeng","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology; Sidra Medicine; Doha Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"issue":"Suppl 2","key":"10.1002\/14651858.CD013743.pub2-BIB0001|cit1","first-page":"39","article-title":"Rifaximine and probiotics in the treatment of mild relapse of left side ulcerative colitis","volume":"45","author":"Bataga","year":"2015","journal-title":"European Journal of Clinical Investigation"},{"issue":"2","key":"10.1002\/14651858.CD013743.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2036.1990.tb00456.x","article-title":"The efficacy of tobramycin in the treatment of ulcerative colitis","volume":"4","author":"Burke","year":"1990","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0003|cit3","unstructured":"Burke DA Your 1990 Alimentary Pharmacology and Therapeutics study Email to: Denis Burke (Denis.Burke@ncic.nhs.uk)"},{"issue":"4","key":"10.1002\/14651858.CD013743.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/00004836-198708000-00011","article-title":"A comparative study of metronidazole and sulfasalazine in active, not severe, ulcerative colitis. An Israeli multicenter trial","volume":"9","author":"Gilat","year":"1987","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD013743.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/00004836-198908000-00008","article-title":"A comparison of metronidazole and sulfasalazine in the maintenance of remission in patients with ulcerative colitis","volume":"11","author":"Gilat","year":"1989","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD013743.pub2-BIB0006|cit6","first-page":"43","article-title":"Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis","volume":"89","author":"Mantzaris","year":"1994","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0007|cit7","unstructured":"Mantzaris GJ Cochrane systematic review Email to: Gerassimos Mantzaris (gjmantzaris@gmail.com)"},{"issue":"3","key":"10.1002\/14651858.CD013743.pub2-BIB0008|cit8","first-page":"454","article-title":"A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis","volume":"92","author":"Mantzaris","year":"1997","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0009|cit9","unstructured":"Mantzaris GJ Cochrane systematic review Email to: Gerassimos Mantzaris (gjmantzaris@gmail.com)"},{"issue":"9","key":"10.1002\/14651858.CD013743.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/003655201750305503","article-title":"A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis","volume":"36","author":"Mantzaris","year":"2001","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0011|cit11","unstructured":"Mantzaris GJ Cochrane systematic review Email to: Gerassimos Mantzaris (gjmantzaris@gmail.com)"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14787210.2021.1856656","article-title":"Adjuvant use of combination of antibiotics in acute severe ulcerative colitis: a placebo controlled randomized trial","volume":"14","author":"Mishra","year":"2020","journal-title":"Expert Review of Anti-Infective Therapy"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0013|cit13","unstructured":"Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis (AAASUC) clinicaltrials.gov\/ct2\/show\/NCT03794765"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0014|cit14","unstructured":"Sharma V Your trial registration NCT03794765 - Antibiotics as an Adjuvant in Patients Email to: Shubhra Mishra (shubhra.mishra91@gmail.com)"},{"issue":"11","key":"10.1002\/14651858.CD013743.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1080\/00365520510023648","article-title":"Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: a randomized, controlled pilot trial with long-term follow-up","volume":"40","author":"Ohkusa","year":"2005","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0016|cit16","unstructured":"Ohkusa T Your 2005 and 2010 studies Email to: Toshifumi Ohkusa (ohkusa@juntendo.ac.jp)"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0017|cit17","unstructured":"Antibiotic combination therapy in patients with active refractory ulcerative colitis: a prospective randomized placebo-controlled multicenter study rctportal.niph.go.jp\/en\/detail?trial_id=C000000078"},{"issue":"8","key":"10.1002\/14651858.CD013743.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/ajg.2010.84","article-title":"Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial","volume":"105","author":"Ohkusa","year":"2010","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0019|cit19","unstructured":"Ohkusa T Your 2005 and 2010 studies Email to: Toshifumi Ohkusa (ohkusa@juntendo.ac.jp)"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD013743.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0016-5085(14)62142-9","article-title":"Ciprofloxacin and probiotic Escherichia coli Nissle as add-on treatment in active ulcerative colitis; a double-blinded randomized placebo controlled clinical trial","volume":"146","author":"Petersen","year":"2014","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD013743.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.crohns.2014.06.001","article-title":"Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial","volume":"8","author":"Petersen","year":"2014","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0022|cit22","unstructured":"F\u00e4rkkil\u00e4 M Your 1998 Gastroenterology study Email to: F\u00e4rkkil\u00e4 Martti (Martti.Farkkila@hus.fi)"},{"issue":"5","key":"10.1002\/14651858.CD013743.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/s0016-5085(98)70076-9","article-title":"Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study","volume":"115","author":"Turunen","year":"1998","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD013743.pub2-BIB0024|cit24","first-page":"392","article-title":"Erythromycin stearate (Erytrameb) in ulcerative colitis","volume":"53","author":"Abdallah","year":"1970","journal-title":"Journal of the Egyptian Medical Association"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD013743.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0016-5085(12)60768-9","article-title":"Oral tacrolimus versus cyclosporine A in patients with moderate to severe ulcerative colitis refractory to corticosteroids","volume":"142","author":"Aoki","year":"2012","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD013743.pub2-BIB0026|cit26","first-page":"986","article-title":"Rifampicin for ulcerative colitis","volume":"86","author":"Borok","year":"1996","journal-title":"South African Medical Journal"},{"issue":"9","key":"10.1002\/14651858.CD013743.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/ibd\/izz006","article-title":"Efficacy of combination antibiotic therapy for refractory pediatric inflammatory bowel disease","volume":"25","author":"Breton","year":"2019","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1","key":"10.1002\/14651858.CD013743.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00054725-199802000-00001","article-title":"Antiinflammatory effects of enterically coated amoxicillin-clavulanic acid in active ulcerative colitis","volume":"4","author":"Casellas","year":"1998","journal-title":"Inflammatory Bowel Diseases"},{"issue":"10","key":"10.1002\/14651858.CD013743.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1136\/gut.27.10.1210","article-title":"Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis","volume":"27","author":"Chapman","year":"1986","journal-title":"Gut"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0030|cit30","first-page":"A566","article-title":"Role of metronidazole in the management of severe ulcerative colitis","volume":"26","author":"Chapman","year":"1985","journal-title":"Gut"},{"issue":"12","key":"10.1002\/14651858.CD013743.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1136\/gut.26.12.1380","article-title":"Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis","volume":"26","author":"Dickinson","year":"1985","journal-title":"Gut"},{"issue":"6","key":"10.1002\/14651858.CD013743.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(20)30716-2","article-title":"Antibiotic pretreatment prior to fecal microbiota transplantation increases rates of remission in patients with mild to moderate ulcerative colitis: results from a pilot randomized clinical trial","volume":"158","author":"El-Nachef","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD013743.pub2-BIB0033|cit33","first-page":"471","article-title":"Use of vancomycin in treating ulcerative colitis","volume":"38","author":"Gardner","year":"1981","journal-title":"American Journal of Hospital Pharmacy"},{"issue":"6","key":"10.1002\/14651858.CD013743.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1023\/a:1026648812439","article-title":"Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial","volume":"44","author":"Gionchetti","year":"1999","journal-title":"Digestive Diseases and Sciences"},{"issue":"4","key":"10.1002\/14651858.CD013743.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/01.MIB.0000215092.85116.6c.","article-title":"Rifaximin for active ulcerative colitis","volume":"12","author":"Guslandi","year":"2006","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1","key":"10.1002\/14651858.CD013743.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.gastro.2020.07.048","article-title":"A phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis","volume":"160","author":"Henn","year":"2021","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD013743.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1684\/hpg.2007.0126","article-title":"Two years combined antibiotic treatment of Crohn's disease with clarithromycin, rifabutin, and clofazimine","volume":"14","author":"Hillaire","year":"2007","journal-title":"Hepato-Gastro"},{"issue":"7","key":"10.1002\/14651858.CD013743.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/j.1440-1746.2006.04533.x","article-title":"Open label trial of clarithromycin therapy in Japanese patients with Crohn's disease","volume":"22","author":"Inoue","year":"2007","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD013743.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/MIB.0000000000000975","article-title":"Changes in intestinal microbiota following combination therapy with fecal microbial transplantation and antibiotics for ulcerative colitis","volume":"23","author":"Ishikawa","year":"2017","journal-title":"Inflammatory Bowel Diseases"},{"issue":"8630","key":"10.1002\/14651858.CD013743.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/s0140-6736(89)91184-7","article-title":"Antimycobacterial therapy ineffective in Crohn's disease after a year","volume":"1","author":"J\u00e4rnerot","year":"1989","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013743.pub2-BIB0041|cit41","first-page":"S4","article-title":"Fluconazole reduces disease activity in active ulcerative colitis: a double-blind randomized placebo-controlled trial","volume":"39","author":"Jena","year":"2020","journal-title":"Indian Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD013743.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1159\/000358141","article-title":"Is rifaximin effective in maintaining remission in Crohn's disease?","volume":"32","author":"Jigaranu","year":"2014","journal-title":"Digestive Diseases"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0043|cit43","unstructured":"A trial of a combination therapy of fecal microbial transplantation and antibiotics for inflammatory bowel disease rctportal.niph.go.jp\/en\/detail?trial_id=UMIN000025846"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0044|cit44","unstructured":"A trial of a combination therapy of fecal microbial transplantation and antibiotics for inflammatory bowel disease rctportal.niph.go.jp\/en\/detail?trial_id=jRCTs031180415"},{"issue":"9","key":"10.1002\/14651858.CD013743.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/apt.12688","article-title":"Adjunct antibiotic combination therapy for steroid-refractory or -dependent ulcerative colitis: an open-label multicentre study","volume":"39","author":"Kato","year":"2014","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD013743.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"e86702","DOI":"10.1371\/journal.pone.0086702","article-title":"Long-term alteration of intestinal microbiota in patients with ulcerative colitis by antibiotic combination therapy","volume":"9","author":"Koido","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1002\/14651858.CD013743.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1097\/MPG.0000000000002034","article-title":"Combination antibiotics improves disease activity and alters microbial communities in children with ulcerative colitis","volume":"67","author":"Kordy","year":"2018","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD013743.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1053\/j.gastro.2007.09.012","article-title":"The Australian antibiotic trial in Crohn's disease: alternative conclusions from the same study","volume":"133","author":"Kuenstner","year":"2007","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD013743.pub2-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007735","article-title":"Antibiotics for induction of remission in ulcerative colitis [withdrawn]","author":"Kumar","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD013743.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2017.11.189","article-title":"Double-blind, randomized, placebo-controlled, crossover trial to evaluate induction of clinical response in patients with moderate-severe Crohn's disease treated with rifaximin","volume":"154","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD013743.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1046\/j.1365-2036.2000.00753.x","article-title":"Open label trial of oral clarithromycin in active Crohn's disease","volume":"14","author":"Leiper","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD013743.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/j.1365-2036.2008.03661.x","article-title":"Clinical trial: randomized study of clarithromycin versus placebo in active Crohn's disease","volume":"27","author":"Leiper","year":"2008","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"Supp 1","key":"10.1002\/14651858.CD013743.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/ecco-jcc\/jjw019.084","article-title":"Azithromycin based therapy for induction of remission in mild to moderate active paediatric Crohn's disease: the multicentre AZithromycin for CROhn's disease AZCRO trial","volume":"10","author":"Levine","year":"2016","journal-title":"Journal of Crohn's and Colitis"},{"issue":"2","key":"10.1002\/14651858.CD013743.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/gutjnl-2017-315199","article-title":"Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease: a randomised controlled trial","volume":"68","author":"Levine","year":"2019","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD013743.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1365-2036.1993.tb00084.x","article-title":"Oral tobramycin in ulcerative colitis: effect on maintenance of remission","volume":"7","author":"Lobo","year":"1993","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD013743.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1574-695X.2009.00550.x","article-title":"Seroprevalence of Fusobacterium varium in ulcerative colitis patients in Japan","volume":"56","author":"Minami","year":"2009","journal-title":"FEMS Immunology & Medical Microbiology"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0057|cit57","unstructured":"A study to investigate efficacy and safety of KBL697 in patients with mild to moderate active ulcerative colitis clinicaltrials.gov\/ct2\/show\/NCT04898348"},{"issue":"8","key":"10.1002\/14651858.CD013743.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1365-2036.2005.02428.x","article-title":"Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy","volume":"21","author":"Nomura","year":"2005","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD013743.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3390\/jcm9061650","article-title":"Matching between donors and ulcerative colitis patients Is important for long-term maintenance after fecal microbiota transplantation","volume":"9","author":"Okahara","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"93","key":"10.1002\/14651858.CD013743.pub2-BIB0060|cit60","first-page":"1016","article-title":"Serial changes of cytokines in active ulcerative colitis: effects of antibiotic combination therapy","volume":"56","author":"Sato","year":"2009","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD013743.pub2-BIB0061|cit61","first-page":"97","article-title":"Rifampicin for ulcerative colitis","volume":"86","author":"Schoonees","year":"1996","journal-title":"South African Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD013743.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1053\/j.gastro.2007.03.031","article-title":"Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn\u2019s disease","volume":"132","author":"Selby","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD013743.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000321811","article-title":"Antibiotic combination therapy for steroid withdrawal in steroid-dependent ulcerative colitis","volume":"83","author":"Terao","year":"2011","journal-title":"Digestion"},{"issue":"11","key":"10.1002\/14651858.CD013743.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/ibd\/izz298","article-title":"Antibiotic cocktail for pediatric acute severe colitis and the microbiome: the PRASCO randomized controlled trial","volume":"26","author":"Turner","year":"2019","journal-title":"Inflammatory Bowel Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013743.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/ecco-jcc\/jjx180.642","article-title":"Manipulating the microbiome in paediatric acute severe colitis with a cocktail of antibiotics: a pilot randomised controlled trial","volume":"18","author":"Turner","year":"2018","journal-title":"Journal of Crohn's and Colitis"},{"issue":"Suppl 209","key":"10.1002\/14651858.CD013743.pub2-BIB0066|cit66","first-page":"36","article-title":"Ciprofloxacin treatment combined with conventional therapy in inflammatory bowel disease. A prospective, double blind, placebo controlled study in two arms","volume":"30","author":"Turunen","year":"1995","journal-title":"4th UEGW Berlin"},{"issue":"1","key":"10.1002\/14651858.CD013743.pub2-BIB0067|cit67","first-page":"282","article-title":"Long-term treatment of ulcerative colitis with ciprofloxacin","volume":"117","author":"Turunen","year":"1999","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013743.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1440-1746.2010.06231.x","article-title":"Efficacy of antibiotic combination therapy in patients with active ulcerative colitis, including refractory or steroid-dependent cases","volume":"25","author":"Uehara","year":"2010","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"15","key":"10.1002\/14651858.CD013743.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.11569\/wcjd.v21.i15.1458","article-title":"Rapamycin for treatment of ulcerative colitis","volume":"21","author":"Wu","year":"2013","journal-title":"World Chinese Journal of Digestology"},{"issue":"2","key":"10.1002\/14651858.CD013743.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"109","DOI":"10.7883\/yoken.66.109","article-title":"Nested culture method improves detection of Fusobacterium from stool in patients with ulcerative colitis","volume":"66","author":"Yukawa","year":"2013","journal-title":"Japanese Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0071|cit71","unstructured":"Comparison of randomized trials of antibiotic combination therapies for patients with ulcerative colitis rctportal.niph.go.jp\/en\/detail?trial_id=UMIN000009811"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0072|cit72","unstructured":"Antibiotic combination therapy for ulcerative colitis rctportal.niph.go.jp\/en\/detail?trial_id=UMIN000017844"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0073|cit73","unstructured":"Triple antibiotics therapy for ulcerative colitis rctportal.niph.go.jp\/en\/detail?trial_id=UMIN000018157"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0074|cit74","unstructured":"Exploratory study of antibiotics combination therapy for moderate to severe ulcerative colitis rctportal.niph.go.jp\/en\/detail?trial_id=UMIN000024520"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0075|cit75","first-page":"A48","article-title":"Combination of antibiotics as adjuvant therapy in acute severe ulcerative colitis: a randomized trial","volume":"69","author":"Mishra","year":"2020","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013743.pub2-BIB0076|cit76","first-page":"S4","article-title":"Combination of intravenous antibiotics in acute severe ulcerative colitis: a placebo controlled randomized trial","volume":"39","author":"Mishra","year":"2020","journal-title":"Indian Society of Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD013743.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/14787210.2021.1856656","article-title":"Adjuvant use of combination of antibiotics in acute severe ulcerative colitis: a placebo controlled randomized trial","volume":"19","author":"Mishra","year":"2021","journal-title":"Expert Review of Anti-infective Therapy"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0078|cit78","unstructured":"Treatment of ulcerative colitis with ciprofloxacin and E. coli Nissle clinicaltrials.gov\/ct2\/show\/NCT01772615"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0079|cit79","unstructured":"Trial of antimicrobials versus placebo in addition to fecal transplant therapy in ulcerative colitis (FMT) clinicaltrials.gov\/ct2\/show\/NCT02606032"},{"issue":"11","key":"10.1002\/14651858.CD013743.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/ibd\/izz298","article-title":"Antibiotic cocktail for pediatric acute severe colitis and the microbiome: the PRASCO randomized controlled trial","volume":"26","author":"Turner","year":"2020","journal-title":"Inflammatory bowel diseases"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0081|cit81","unstructured":"Antimicrobial therapy for ulcerative colitis (UC) clinicaltrials.gov\/ct2\/show\/NCT03986996"},{"issue":"10","key":"10.1002\/14651858.CD013743.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/MCG.0000000000000660","article-title":"World Gastroenterology Organisation global guidelines inflammatory bowel disease: update August 2015","volume":"50","author":"Bernstein","year":"2016","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD013743.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.autrev.2014.01.028","article-title":"Diagnosis and classification of ulcerative colitis","volume":"13","author":"Conrad","year":"2014","journal-title":"Autoimmunity Reviews"},{"issue":"28","key":"10.1002\/14651858.CD013743.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"9458","DOI":"10.3748\/wjg.v20.i28.9458","article-title":"Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis","volume":"20","author":"da Silva","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD013743.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","article-title":"AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis","volume":"158","author":"Feuerstein","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0087|cit87","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"issue":"7","key":"10.1002\/14651858.CD013743.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjx009","article-title":"Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management","volume":"11","author":"Harbord","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"issue":"7414","key":"10.1002\/14651858.CD013743.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0090|cit90","unstructured":"Higgins JP, Green S, editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011"},{"issue":"3","key":"10.1002\/14651858.CD013743.pub2-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007443.pub3","article-title":"Probiotics for maintenance of remission in ulcerative colitis","author":"Iheozor-Ejiofor","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013743.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/2050640620967899","article-title":"Sample-size estimation is not reported in 24% of randomised controlled trials of inflammatory bowel disease: a systematic review","volume":"9","author":"Iheozor-Ejiofor","year":"2021","journal-title":"United European Gastroenterology Journal"},{"issue":"3","key":"10.1002\/14651858.CD013743.pub2-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005573.pub3","article-title":"Probiotics for induction of remission in ulcerative colitis","author":"Kaur","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD013743.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/ajg.2011.72","article-title":"Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis","volume":"106","author":"Khan","year":"2011","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD013743.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology"},{"issue":"8706","key":"10.1002\/14651858.CD013743.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0140-6736(90)91521-B","article-title":"Preliminary report: cyclosporin in treatment of severe active ulcerative colitis","volume":"336","author":"Lichtiger","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0097|cit97","first-page":"393","article-title":"The value of rectal biopsy in the diagnosis of ulcerative colitis","volume":"30","author":"Matts","year":"1961","journal-title":"Quarterly Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013743.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3748\/wjg.v22.i3.1078","article-title":"Role of antibiotics for treatment of inflammatory bowel disease","volume":"22","author":"Nitzan","year":"2016","journal-title":"World Journal of Gastroenterology"},{"issue":"9853","key":"10.1002\/14651858.CD013743.pub2-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Ord\u00e1s","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD013743.pub2-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/gut.2003.025403","article-title":"Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease","volume":"53","author":"Ott","year":"2004","journal-title":"Gut"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"2920-5","DOI":"10.1007\/s10620-007-9760-1","article-title":"A meta-analysis of antibiotic therapy for active ulcerative colitis","volume":"52","author":"Rahimi","year":"2007","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD013743.pub2-BIB0102|cit102","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2020"},{"issue":"3","key":"10.1002\/14651858.CD013743.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"American Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD013743.pub2-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3748\/wjg.v19.i5.648","article-title":"Use of antibiotics in the treatment of Crohn's disease","volume":"19","author":"Scribano","year":"2013","journal-title":"World Journal of Gastroenterology: WJG"},{"issue":"5","key":"10.1002\/14651858.CD013743.pub2-BIB0105|cit105","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1053\/j.gastro.2020.01.007","article-title":"AGA technical review on the management of moderate to severe ulcerative colitis","volume":"158","author":"Singh","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD013743.pub2-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/gast.2002.30294","article-title":"Mucosal flora in inflammatory bowel disease","volume":"122","author":"Swidsinski","year":"2002","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD013743.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gut.38.6.905","article-title":"Predicting outcome in severe ulcerative colitis","volume":"38","author":"Travis","year":"1996","journal-title":"Gut"},{"issue":"4947","key":"10.1002\/14651858.CD013743.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial","volume":"2","author":"Truelove","year":"1955","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD013743.pub2-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/MPG.0000000000002036","article-title":"Management of paediatric ulcerative colitis, part 2: acute severe colitis - an evidence-based consensus guideline from the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition","volume":"67","author":"Turner","year":"2018","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD013743.pub2-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"e0170034","DOI":"10.1371\/journal.pone.0170034","article-title":"Intestinal bacteria composition and translocation of bacteria in inflammatory bowel disease","volume":"12","author":"Vrakas","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1002\/14651858.CD013743.pub2-BIB0111|cit111","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013743","article-title":"Antibiotics for the induction and maintenance of remission in ulcerative colitis","author":"Gordon","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T15:18:16Z","timestamp":1679239096000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013743.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gut Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":111,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013743.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]}}}